The Cartagena Protocol on Biosafety that was adopted by governments on 29 January 2000 is the main international legally binding treaty that regulates ?the safe transfer, handling and use of living modified organisms resulting from modern biotechnology? that may have adverse effects on the conservation and sustainable use of biological diversity, taking also into account risks to human health?.

It is significant as the first global treaty to attempt to contribute to the protection of biodiversity and human health in this field, and as the first treaty to operationalise the precautionary approach in decision-making relating to imports under the Protocol. As of 22 February 2005, there are 113 Parties to the Protocol.

Although the Protocol focuses on transboundary movements of GMOs, its provisions do influence national and regional biosafety policies and laws, bearing in mind that the Protocol sets minimum requirements and Parties have the right to formulate more comprehensive national laws with higher standards. This is reaffirmed in Article 2(4).

Meanwhile, work and standard setting are also taking place in other international fora, such as the Codex Alimentarius, the International Plant Protection Convention and the International Office of Epizootics, the UN Food and Agriculture Organisation and the World Health Organisation.

The linkages among trade, environment and health means that developments at the World Trade Organisation also impact on biosafety and vice versa.

A field of growing importance is the development of biological weapons as part of biodefence programmes where the adequacy of global rules and standards needs examinination.

Renewed Calls to Ban ‘Terminator Technology’

As governments gathered for the UN CBD Working Group meeting in Granada in Jan 2006, indigenous peoples, farmers’ groups and NGOs renewed their calls for an international ban on ‘Terminator Technology’. […]

Global Rules on Access and Benefit-sharing of Biodiversity Take Shape in Granada Meeting

The latest round of UN talks held in Granada, Jan 2006 on an international agreement on access and benefit-sharing reflected the all-too-familiar tensions and conflicts between the developed and developing countries. […]

The Biodiversity-IPRs Debate

A UN meeting held in Jan 2006 was an opportune occasion to revisit the difficult issues that states, indigenuous and local communities need to grapple with as they come to grips with the interplay of biodiversity and IPRs. […]

Analysis of key decisions at Biosafety Protocol meeting

This is an analysis on key decisions taken at the 3rd meeting of the Parties of the Cartagena Protocol on Biosafety which met from 13-17 March in Curitiba, Brazil. […]

Biosafety Protocol Reaches Agreement on Documentation for GMO Shipments

At the 3rd meeting of the Parties of the Cartagena Protocol on Biosafety in Brazil, agreement was finally reached on international documentation requirements for bulk shipments of genetically modified commodity grains. […]

Biotec Trade Watch

A website that publishes videos and information about the negotiations and side events at the 3rd Meeting of Parties of the Cartagena Protocol on Biosafety in Brazil. […]

TWN Assessment of Interim Report on WTO Dispute

This is an assessment of the interim report of the WTO Panel considering the case “European Communities – Measures Affecting the Approval and Marketing of Biotech Products” which was made available to the parties in the dispute. […]

South African Civil Society Submission to the Open-Ended Working Group of Legal and Technical Experts on Liability and Redress in the context of the Cartagena Protocol on Biosafety

Submission from South African Civil Societies to the Open-Ended Working Group of Legal and Technical Experts on Liability and Redress in the context of the Cartagena Protocol on Biosafety […]

Submission of Third World Network relating to the development of a liability and redress regime under the Cartagena Protocol on Biosafety

Submission from Third World Network to the Open-Ended Working Group of Legal and Technical Experts on Liability and Redress in the context of the Cartagena Protocol on Biosafety […]

No WHA approval for expanding smallpox virus research

A proposal by a WHO advisory committee to preserve stocks of the smallpox virus in their laboratories for further research, including genetic engineering, was not approved by the World Health Assembly. […]